These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3327449)

  • 21. Mode of action of estramustine phosphate in hormone dependent and hormone non-dependent prostate cancer.
    Hedlund PO
    Prog Clin Biol Res; 1985; 185A():197-202. PubMed ID: 3898129
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane.
    Henriksson R; Bjermer L; Von Schoultz E; Grankvist K
    Anticancer Res; 1990; 10(2A):303-9. PubMed ID: 2346305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estramustine phosphate in prostate cancer. Seminar.
    Urology; 1984 Jun; 23(6 Suppl):1-88. PubMed ID: 6730139
    [No Abstract]   [Full Text] [Related]  

  • 24. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2.
    Fridén B; Wallin M; Deinum J; Prasad V; Luduena R
    Arch Biochem Biophys; 1987 Aug; 257(1):123-30. PubMed ID: 3115177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT; Jones AG
    Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of the interdependent localization of vimentin and microtubules in neoplastic myoepithelial cells.
    Jaeger RG; Jaeger MM; Araújo VC; Kachar B
    Cell Motil Cytoskeleton; 1995; 32(4):289-98. PubMed ID: 8608607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 34. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F; Esposti PL; Andersson L
    Scand J Urol Nephrol Suppl; 1980; 55():139-42. PubMed ID: 6938017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with estramustine phosphate.
    Nilsson T; Wear JB
    Wis Med J; 1976 Nov; 75(11):S121-S123. PubMed ID: 1007313
    [No Abstract]   [Full Text] [Related]  

  • 36. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.
    Hartley-Asp B
    Prostate; 1984; 5(1):93-100. PubMed ID: 6694918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estracit in the therapy of prostatic carcinoma].
    Oresić V; Nola P; Mrsić Z; Pasini J
    Acta Chir Iugosl; 1980; 27 Suppl 1():587-9. PubMed ID: 7424445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 39. [Estracyt and radiotherapy in the treatment of prostatic cancer].
    Van Regemorter G; Germeau F
    Acta Urol Belg; 1980 Jan; 48(1):138-48. PubMed ID: 7435350
    [No Abstract]   [Full Text] [Related]  

  • 40. The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs.
    Santibañez JF; Maccioni RB; Martínez J
    Cell Biochem Funct; 1995 Sep; 13(3):217-25. PubMed ID: 7554101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.